Cargando…
Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603611/ http://dx.doi.org/10.1186/2052-3211-8-S1-P17 |
| _version_ | 1782394923385880576 |
|---|---|
| author | Kazakov, Rossen M Petrova, Penka I |
| author_facet | Kazakov, Rossen M Petrova, Penka I |
| author_sort | Kazakov, Rossen M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4603611 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46036112015-10-14 Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment Kazakov, Rossen M Petrova, Penka I J Pharm Policy Pract Poster Presentation BioMed Central 2015-10-05 /pmc/articles/PMC4603611/ http://dx.doi.org/10.1186/2052-3211-8-S1-P17 Text en Copyright © 2015 Kazakov et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Kazakov, Rossen M Petrova, Penka I Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment |
| title | Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment |
| title_full | Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment |
| title_fullStr | Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment |
| title_full_unstemmed | Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment |
| title_short | Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment |
| title_sort | reimbursement policy optimization for angiotensin-converting enzyme (ace) inhibitors in bulgaria: controlling expenditure without undermining access to treatment |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603611/ http://dx.doi.org/10.1186/2052-3211-8-S1-P17 |
| work_keys_str_mv | AT kazakovrossenm reimbursementpolicyoptimizationforangiotensinconvertingenzymeaceinhibitorsinbulgariacontrollingexpenditurewithoutunderminingaccesstotreatment AT petrovapenkai reimbursementpolicyoptimizationforangiotensinconvertingenzymeaceinhibitorsinbulgariacontrollingexpenditurewithoutunderminingaccesstotreatment |